Premature babies diagnosed with bronchopulmonary dysplasia (BPD) face the risk of rehospitalization, delayed brain development, and respiratory problems throughout childhood. No FDA-approved therapies are available for BPD—which is why the new FDA designation for AyuVis's drug candidate, AVR-48, could lead to game-changing impact.
Alfonso Montiel; CEO of Dallas-based SilverStone Health; was inspired to become a hospice volunteer when a family member neared the end of life. It led to a new calling.; [Photo: Silverstone Health]
Fort Worth-based Sanara MedTech Inc. has announced the appointments of Jake Waldrop as chief operating officer and Tyler Palmer as chief corporate development and strategy officer.
Sanara is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical, chronic wound, and skincare markets....
Rendering of Children’s Health and UT Southwestern's new pediatric campus [Image: Children’s Health]
Longtime nonprofit executive and community relations veteran Monica Christopher has been named the inaugural president of Texas Woman’s University’s Dallas campus and will begin on Feb....